1992
DOI: 10.1096/fasebj.6.8.1592205
|View full text |Cite
|
Sign up to set email alerts
|

Biochemistry and physiology of n‐3 fatty acids

Abstract: Considering the n-3 fatty acids to be partial agonists relative to n-6 fatty acids helps consolidate into a unified interpretation the many diverse reports and controversies on the actions of these two types of essential fatty acids. Some research reports illustrate the similarities between these two types and some emphasize the differences, leaving readers to evaluate the status of n-3 fatty acids from a viewpoint that is conceptually similar to regarding a glass of water as half empty or half full. Both n-3 … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
143
1
7

Year Published

1994
1994
2018
2018

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 288 publications
(154 citation statements)
references
References 39 publications
3
143
1
7
Order By: Relevance
“…In experimental animal models of mammary carcinogenesis, high n-6 PUFA diets stimulate mammary tumour growth and development as well as metastases (Carroll, 1986;Erickson & Hubbard, 1990), while long-chain n-3 PUFA (Adams et al, 1990;Cave, 1991) or 18:3,, 3 enrichment of the diet (Tinsley et al, 1981;Kamano et al, 1989;Fritsche & Johnston, 1990;Hirose et al, 1990) inhibits tumour growth. Therefore, in the rat, the effects of dietary long-chain n-3 PUFAs seem to oppose the stimulation of tumour growth induced by n-6 essential fatty acids (Lands, 1992), and 18:3,3 appears also to bear inhibitory properties.…”
Section: Deamentioning
confidence: 97%
“…In experimental animal models of mammary carcinogenesis, high n-6 PUFA diets stimulate mammary tumour growth and development as well as metastases (Carroll, 1986;Erickson & Hubbard, 1990), while long-chain n-3 PUFA (Adams et al, 1990;Cave, 1991) or 18:3,, 3 enrichment of the diet (Tinsley et al, 1981;Kamano et al, 1989;Fritsche & Johnston, 1990;Hirose et al, 1990) inhibits tumour growth. Therefore, in the rat, the effects of dietary long-chain n-3 PUFAs seem to oppose the stimulation of tumour growth induced by n-6 essential fatty acids (Lands, 1992), and 18:3,3 appears also to bear inhibitory properties.…”
Section: Deamentioning
confidence: 97%
“…24 Part of these effects are related to changes in plasma membrane fatty acid composition 25 and eicosanoid biosynthesis. 26,27 On the other hand, n-3 PUFAs suppress fatty acid synthesis, 28 increase oxidation of fatty acids 28 and reduce triacylglycerol synthesis. 29 In general the n-3 fatty acids, particularly Fat cell data and fatty acid composition in obesity M Garaulet et al eicosapentaenoic (20:5n-3) and the docosahexaenoic (22:6 n-3) acids, are closely associated with the expression of the genes encoding lipogenic (FAS, LPL) enzymes, lipolytic (HSL), glyceroneogenic (PEPCK) enzymes, the transcription factor (C/EBPa) and leptin.…”
Section: Fat Cell Data and Fatty Acid Composition In Obesity M Garaulmentioning
confidence: 99%
“…Biochemical alterations in the structure and function of neuronal membranes can affect the intracellular and extracellular processes and synaptic neurotransmission, all of which may be involved in the pathophysiology of mood disorders (Carlezon et al, 2005;Lands, 1992;Nomura et al, 2001;Pacheco and Jope, 1996). Pyrimidines have also shown antidepressant-like effects in animal studies (Carlezon et al, 2002(Carlezon et al, , 2005, which may stem from the alteration of cerebral neurotransmission (Carlezon et al, 2002;Martinet et al, 1978Martinet et al, , 1979.…”
Section: Introductionmentioning
confidence: 99%